Pramlintide
Also known as: Symlin
The synthetic amylin analog FDA-approved as adjunctive therapy with insulin, the biochemical forerunner to cagrilintide.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~48 minutes
60–120 mcg with meals
Subcutaneous injection
Mechanism of Action
Recreates the body's natural bi-hormonal response to feeding by slowing gastric emptying, suppressing glucagon, and promoting satiety.
Key Research Areas
Frequently Asked Questions
What is Pramlintide?▾
How does Pramlintide work?▾
What is the recommended dosage for Pramlintide?▾
What is the half-life of Pramlintide?▾
Is Pramlintide FDA approved?▾
Ready to get started with Pramlintide?
Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.
Research Disclaimer
The information provided about Pramlintide is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.